九洲集團(300040.SZ):豐潤風電擬以2.88億元受讓融和一號持有的5家公司51%股權
格隆匯2月28日丨九洲集團(300040.SZ)公佈,公司控股的股權投資基金融和電投一號(嘉興)創業投資合夥企業(有限合夥)(簡稱“融和一號”)擬與華電福新能源發展有限公司全資子公司七台河豐潤風力發電有限公司(簡稱“豐潤風電”)簽訂股權轉讓協議,將其持有的泰來宏浩風力發電有限公司、泰來環球光伏電力有限公司、安達市億晶新能源發電有限公司、安達市晟暉新能源科技有限公司、訥河齊能光伏電力開發有限公司(統稱為“5家公司”)51%股權轉讓給豐潤風電,轉讓價格為合計約2.88億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.